Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Share-based Compensation (2016 - 2025)

Amphastar Pharmaceuticals has reported Share-based Compensation over the past 13 years, most recently at $6.2 million for Q4 2025.

  • Quarterly results put Share-based Compensation at $6.2 million for Q4 2025, up 10.17% from a year ago — trailing twelve months through Dec 2025 was $27.3 million (up 11.94% YoY), and the annual figure for FY2025 was $27.3 million, up 11.94%.
  • Share-based Compensation for Q4 2025 was $6.2 million at Amphastar Pharmaceuticals, down from $6.3 million in the prior quarter.
  • Over the last five years, Share-based Compensation for AMPH hit a ceiling of $8.4 million in Q1 2025 and a floor of $3.8 million in Q4 2021.
  • Median Share-based Compensation over the past 5 years was $5.3 million (2022), compared with a mean of $5.4 million.
  • Biggest five-year swings in Share-based Compensation: plummeted 30.39% in 2022 and later increased 21.85% in 2024.
  • Amphastar Pharmaceuticals' Share-based Compensation stood at $3.8 million in 2021, then rose by 11.79% to $4.3 million in 2022, then rose by 7.39% to $4.6 million in 2023, then rose by 21.85% to $5.6 million in 2024, then increased by 10.17% to $6.2 million in 2025.
  • The last three reported values for Share-based Compensation were $6.2 million (Q4 2025), $6.3 million (Q3 2025), and $6.4 million (Q2 2025) per Business Quant data.